Evaluating vaginal closure techniques during colporrhaphy and effects on post-operative pain

Prospective randomised trial evaluating vaginal closure techniques during colporrhaphy and effects on post-operative pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN83130211

Enrollment

110

Registered

2012-02-10

Start date

2012-06-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterovaginal prolapse Urological and Genital Diseases Uterovaginal prolapse, unspecified

Interventions

Group 1: closure of the vaginal skin with interrupted polyglycolic acid sutures Group 2: closure of the vaginal skin with continuous unlocked polyglycolic acid sutures

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Any patient undergoing anterior and/or posterior colporrhaphy and/or perineorrhaphy with or without vaginal hysterectomy

Exclusion criteria

Exclusion criteria: Patients receiving vaginal mesh repairs for prolapse, or concomitant surgical procedures ? such as mid-urethral tape, vault suspension procedures including sacrospinous ligament fixation and sacrocolpopexy, total abdominal hysterectomy

Design outcomes

Primary

Measure	Time frame
Post-operative pain immediately before pack removal, and 3 hours after pack removal. All packs will be removed 24 hours after surgery. Pain will be assessed by 10 point visual analogue scale score	—

Secondary

Measure	Time frame
1. Incidence of re-attendance for bleeding or discharge 2. Incidence of clinically diagnosed pelvic haematoma (attendance or admission with vaginal bleeding, ± fever, ± pain, ± ultrasound detection of haemotoma if clinically indicated) 3. Sexual dysfunction at 3 month follow-up Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12) for women who are sexually active 4. Prolapse stage (assesed by POPQ) of anterior and posterior compartment at 3 month follow up	—

Measure

Time frame

1. Incidence of re-attendance for bleeding or discharge 2. Incidence of clinically diagnosed pelvic haematoma (attendance or admission with vaginal bleeding, ± fever, ± pain, ± ultrasound detection of haemotoma if clinically indicated) 3. Sexual dysfunction at 3 month follow-up Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12) for women who are sexually active 4. Prolapse stage (assesed by POPQ) of anterior and posterior compartment at 3 month follow up

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026